Pharmacovigilance Africa, PAVIA

Research and capacity building consortium funded by the European and Developing Countries Clinical Trials Partnership, which ran from 2018 to 2023 led by the Amsterdam Institute for Global Health and Development with partners in Ethiopia, Nigeria, Eswatini and Tanzania. Worked to strengthen pharmacovigilance in those countries, particularly around new treatment regimens for multidrug resistant tuberculosis, with support for adverse event reporting, causality assessment and signal detection, national policies and guidelines and blended electronic learning training programmes.